And ExodusPoint takes a 6.30% $KROS stake. ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏
Wednesday, November 19, 2025
|
|
|
Every day, we sift through the filings to spot where the real conviction lies – cutting through the noise to highlight the most meaningful insider moves. 📌 Mach Natural Resources $MNR — CEO Tom L. Ward bought $1.05 million worth of shares per a fresh Form 4.
This is fresh insider support in a newly listed E&P name that's lost a third of its value since going public. 📌 TransMedics $TMDX — CEO Waleed Hassanein bought $1 million of his stock per a new Form 4.
The C-suite is stepping in on a medical devices name stuck in the middle of a multi-month range as rotation starts to favor Health Care again. Here's The Hot Corner, with data from November 18, 2025: | Click the table to enlarge it. |
📌 Keros Therapeutics $KROS — ExodusPoint filed a new 13G at 6.30%.
A multi-strategy hedge fund is building a passive position in a name looking to complete a base and fill a massive gap. 📌 Compass Minerals $CMP — M Partners Fund filed a new 13G at 5.49%.
A value-tilted fund takes an initial stake in the beaten-down minerals producer. Interesting timing as rotation is starting to enter the commodity complex. |
|
|
Alfonso Depablos | Director of Research, All Star Charts |
|
|
Stock Market Media emails are a financial publication of general circulation and only offers impersonal advice, not tailored to individual needs of a specific client or group. Any comments or statements made herein do not necessarily reflect those of Stock Market Media LLC or its affiliates (collectively, "Stock Market Media") and do not constitute buy or sell recommendations. Unless specifically indicated, this message is not an official confirmation of any transaction. The contents of any email communications to or from Stock Market Media may be monitored or reviewed at Stock Market Media's discretion. Stock Market Media accepts no responsibility for any loss or damage arising in any way from the use of this transmission and any attachments; it is the responsibility of the recipient to ensure that they are virus free. If you reply to this email, please note that we are a public investor and do not want any material non-public information. We do not agree to keep confidential any information you provide and do not agree to any restrictions on our trading activity, except pursuant to a written confidentiality agreement executed by Stock Market Media. |
Want to change how you receive these emails? You can manage your preferences here unsubscribe. © 2025 Stock Market Media 624 Broadway, Suite 405 San Diego, CA 92101 |
|
|
|